MyFinsight
Home
Blog
About
Marketable securities,
available for sale
$388,390K
(-29.46%↓ Y/Y)
Cash and cash
equivalents
$72,319K
(66.62%↑ Y/Y)
Prepaid expenses and
other assets
$6,445K
(-30.42%↓ Y/Y)
Current assets held for
sale
$4,364K
Total current assets
$471,518K
(-21.84%↓ Y/Y)
Property and equipment,
net
$6,892K
(-19.81%↓ Y/Y)
Operating lease
right-of-use asset
$1,278K
(-13.88%↓ Y/Y)
Total assets
$479,688K
(-21.79%↓ Y/Y)
Total liabilities and
stockholders' equity
$479,688K
(-21.79%↓ Y/Y)
Total stockholders'
equity
$448,077K
(-23.93%↓ Y/Y)
Total liabilities
$31,611K
(30.28%↑ Y/Y)
Accumulated deficit
-$652,711K
(-43.30%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$500K
(-345.10%↓ Y/Y)
Additional paid-in capital
$1,101,278K
(5.45%↑ Y/Y)
Total current
liabilities
$29,042K
(38.98%↑ Y/Y)
Operating lease
liability, net of current...
$2,569K
(-23.70%↓ Y/Y)
Common stock, .0001 par
value per share...
$10K
(0.00%↑ Y/Y)
Current liabilities
held for sale
$9,590K
Accrued compensation
$8,576K
(52.16%↑ Y/Y)
Accrued other expenses
$5,189K
(-12.58%↓ Y/Y)
Accounts payable
$4,666K
(-43.92%↓ Y/Y)
Operating lease
liability, current portion
$1,021K
(1.69%↑ Y/Y)
Back
Back
Balance Sheet
Edgewise Therapeutics, Inc. (EWTX)
Edgewise Therapeutics, Inc. (EWTX)
source: myfinsight.com